Clinical Trial Update: A Multi-Center Study To Evaluate Multiple Doses of NT100 Following IVF In Women With Repeated IVF Failures (Thrive-IVF) [Phase 2]

View source ↗

Summary

A Phase 2 multi-center trial evaluating multiple doses of NT100 in women with repeated IVF failures has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• NT100

Snippet

Sponsor: Nora Therapeutics, Inc. | Conditions: Repeated IVF Failure | Phase 2 | Status: COMPLETED